Selection of A Device for delivery of Aerosol to the Lung Parenchyma

Heyder J , Gebbart J , Rudolf G , Stahlhofen W. Physical factors determining particle deposition in the human respiratory tract. J Aerosol Sci 1980;11:505–515.

Brain JD , Blanchard JD . Mechanisms of particle deposition and clearance. In: Aerosols in medicine: principles, diagnosis and therapy. Moren F , Dolovich M , Newhouse MT , Newman SP , editors. Amsterdam: Elsevier Science Publishers 1993:117–156.

Newman SP , Pavia D , Moren F , Sheahan NF , Clarke SW . Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981;36:52–55.

Dolovich M. Physical principles underlying aerosol therapy. J Aerosol Med 1989;2(2):171–186.

Hager J , Gober K-H , Löhr J-P , Dürr M. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers. J Aerosol Med 1992;5(2):65–79.

Matthys H , Herceg R. Dosing strategies for aerosol delivery to the lung parenchyma, with specific recommendations for pentamidine. Respir Care 1991;36(9):980–993.

Smith DW , Frankel LR , Mathers LH , Tang ATS , Ariagno RL , Prober CG . A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991;325:24–29.

Mason JW , Miller WC , Small S. Comparison of aerosol delivery via Circulaire system vs conventional small volume nebulizer. Respir Care 1994;39(12):1157–1161.

Dubois J , Bartter T , Gryn J , Pratter MR . The physiologic effects of inhaled amphotericin B. Chest 1995;108(3):750–753.

Demers RR , Parker J , Frankel LR , Smith DW . Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care 1986;31(12):1188–1195.

Hess DR , Kacmarek RM . Chapter 30. Secretion clearance, positioning, and inhaled aerosol medication. In: Essentials of mechanical ventilation. New York: McGraw-Hill 1996:205.

Waskin H. Toxicology of antimicrobial aerosols: a review of aerosolized ribavirin and pentamidine. Respir Care 1991;36(9):1026–1036.

Fallat RJ , Kandal K. Aerosol exhaust: escape of aerosolized medication into the patient and caregiver's environment. Respir Care 1991;36(9):1008–1016.

Harrison R. Assessing exposures of health care personnel to aerosols of ribavirin-California. MMWR 1988;37:560–568.

Harrison R. Reproductive risk assessment with occupational exposure to ribavirin aerosol. Pediatr Infect Dis J 1990;9(suppl):S102–S105.

Arnold SD , Buchan RM . Exposure to ribavirin aerosol. Appl Occup Environ Hyg 1991;6:271–279.

Rodriguez WJ , Bui RH , Connor JD , Kim HW , Brandt CA , Parrott RH , et al. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother 1987;31:1143–1146.

Diamond SA , Dupuis LL . Contact lens damage due to ribavirin exposure (letter). DICP 1989;23:428–9.

Adderley RJ . Safety of ribavirin with mechanical ventilation. Pediatr Infect Dis J 1990;9(Suppl):S112–S114.

Massachusetts Department of Labor and Industries, Division of Occupational Hygiene. Ribavirin alert DOH #1558, July 1989.

Kacmarek RM , Kratohvil J. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration. Respir Care 1992;37:37–45.

Charney W , Corkery KJ , Kraemer R. Engineering administration controls to contain the delivery of aerosolized ribavirin: results of simulation and application to one patient. Respir Care 1990;35:1042–1048.

Cefaratt JL , Steinberg EA . An alternative method for delivery of ribavirin to nonventilated pediatric patients. Respir Care 1992;37:877–881.

Beck-Sague C , Dooley SW , Hutton MD , Otten J , Breeden A , Crawford JT , et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268(10):1280–1286.

Witek TJ , Schachter EN . Pharmacology and therapeutics in respiratory care, Philadelphia: WB Saunders 1994:304.

Faculty and Working Group . American Association for Respiratory Care. Aerosol Consensus Conference Statement-1991. Respir Care 1991;36:916–921.

Dooley SW , Castro KG , Hutton MD , Mullan RJ , Polder JA , Snider DE Jr. Guidelines for preventing the transmission of tuberculosis in health-care setting, with special focus on HIV-related issues. MMWR 1990;39(no. RR-17).

Centers for Disease Control & Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Washington DC: Federal Register 1994;59(208), Friday Oct 28, 1994:54242–54303.

Newman SP . Aerosol generators and delivery systems. Respir Care 1991;36:939–951.

Raabe OG , Lee JIC , Wong GA . A signal actuated nebulizer for use with breathing machines. J Aerosol Med 1989;2(2):201–210.

Newman SP , Bateman JRM , Pavia D , Clarke SW . The importance of breath-holding following the inhalation of pressurized aerosol bronchodilators. In: Baran D , editor. Recent advances in aerosol therapy: first Belgian symposium on aerosols in medicine. Brussels 1979:117–122.

Brain JD , Blanchard JD . Aerosols. In: Bronchial asthma: mechanisms and therapeutics, third edition. Weiss EB , Stein M , editors. Boston: Little Brown & Co, 1993.

Hallworth GW . The formulation and evaluation of pressurized metered dose inhalers. In: Ganderton D , Jones T , eds. Drug delivery to the respiratory tract. Chichester, England: Ellis Horwood. 1987:87–118.

Wiener MV . How to formulate aerosols to obtain the desired spray pattern. Soc Cos Chem 1958;9:289–297.

Kim CS , Trujillo D , Sackner MA . Size aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 1985;132:137–142.

Dolovich M , Ruffin RE , Roberts R , Newhouse MT . Optimal delivery of aerosols from metered dose inhalers. Chest 1981;80(suppl):911–915.

Hughes JM , Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 1987;32:111–113.

MacIntyre NR , Silver RM , Miller CW , Schuler F , Coleman RE . Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13:81–84.

Fuller HD , Dolovich MB , Posmituck G , Pack WW , Newhouse MT . Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis 1990;141:440–444.

Dahlback M , Wollmer P , Drefeldt B , Johnson B. Controlled aerosol delivery during mechanical ventilation. J Aerosol Med 1989;4:339–347.

Rozycki HJ , Byron PR , Dailey K , Gutcher GR . Evaluation of a system for the delivery of inhaled beclomethasone dipropionate to intubated neonates. Dev Pharmacol Ther 1991;16(2):65–70.

Cameron D , Arnot R , Clay M , Silverman M. Aerosol delivery in neonatal ventilator circuits: a rabbit lung model. Pediatr Pulmonol 1991;10(3):208–213.

Crogan SJ , Bishop MJ . Delivery efficiency of metered dose aerosols given via endotracheal tube. Anesthesiology 1989;70:1008–1010.

Bishop MJ , Larson RP , Buschman DL . Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/adapter used. Anesthesiology 1990;73(6):1263–1265.

Ebert J , Adams AB , Green-Eide B. an evaluation of MDI spacers and adapters: their effect on the respirable volume of medication. Respir Care 1992;37:862–868.

Newhouse MT , Dolovich M. Aerosol therapy in children: basic mechanisms of pediatric respiratory disease: cellular and integrative. BC Decker 1991.

American Association for Respiratory Care. Clinical practice guideline: selection of aerosol delivery device. Respir Care 1992;37:891–897.

Fink J. Humidity and aerosol therapy. In: Scanlan CL , Spearman CB , Sheldon RL , editors. Egan's fundamentals of respiratory care, sixth ed. St Louis: Mosby-Yearbook 1995:676–696.

Mercer TT , Tillery MI , Chow HY . Operating characteristics of some compressed-air nebulizers. Am Ind Hyg Assoc J 1968;29(1):66–78.

Young HW , Domnik JW , Walker JS , Larson EW . Continuous aerosol therapy system using a modified Collison nebulizer. J Clin Microbiol 1977;5(2):131–136.

Robig G , Gebhart J , Porstendorfer J. [Investigations on the stability of droplets from medical jet and ultrasound aerosol atomizers (author's transl)] Z Erkr Atmungsorgane 1977;149(3):372–379.

Phipps PR , Gonda I. Droplets produced by medical nebulizers: some factors affecting their size and solute concentration. Chest 1990;97(6):1327–1332.

Doershuk CF , Mathews LW , Gillespie CT , Lough MD , Spector S. Evaluation of jet type and ultrasonic nebulizers in mist tent therapy for cystic fibrosis. Pediatrics 1968;41:723–732.

Boucher RGM , Kreuter J. Fundamentals of the ultrasonic atomization of medicated solutions. Ann Allergy 1968;26:59.

Lewis RA , Ellis CJ , Fleming JS , Balachandran W. Ultrasonic and jet nebulizers: differences in the physical properties and fractional deposition on the airway responses to nebulized water and saline aerosols (abstract). Thorax 1984;39:712.

Smith Al . Principles of microbiology. St Louis: CV Mosby, 1969:235–236.

Boucher RM , Pisano A. Sterilizing effect of high intensity airborne sound and ultrasound. Ultrasonics 1966;14:199.

Centers for Disease Control. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377–382,387-388.

ECRI. Tuberculosis, Part II: respirators and recommendations. Technology for Respiratory Therapy. 1992;13(1):1–4.

Center for Disease Control and Prevention. Guideline for the prevention of nosocomial pneumonia. Respir Care 1994;39(12):1191–1236.

Sheth NK , Post GT , Wisniewski TR , Uttech BV . Multidose vials versus single-dose vials: a study in sterility and cost-effectiveness. J Clin Microbiol 1983;17(2):377–379.

Longfield R , Longfield J , Smith LP , Hyams KC , Strohmer ME . Multidose medication vial sterility: an in-use study and a review of the literature. Infect Control 1984;5(4):165–169.

Allen SC , Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 1986;80:45–49.

Anzueto A , Baughman RP , Guntupalli KK , Weg JG , Wiedemann HP , Raventos AA , et al. for the Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334(22):1417–1421.

Ballard RD , Bogin RM , Pak J. Assessment of bronchodilator response to a B-adrenergic delivered from an ultrasonic nebulizer. Chest 1991;100:410–415.

Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related tissues. MMWR 1990;39(RR-17):1–29.

Dolovich M , Chambers C , Mazza M , Newhouse MT . Relative efficiency of four metered dose inhaler (MDI) holding chambers (HC) compared to albuterol MDI. Presented at American Lung Association American Thoracic Society 1992 International Conference at the Symposium on Aerosol Delivery Systems.

Fiel SB , Fuchs HJ , Johnson C , Gonda I , Clark AR , and the Pulmozyme rhDNase Study Group. Comparison of three jet nebulizer aerosol delivery systems to administer recombinant human DNase I to patients with cystic fibrosis. Chest 1995;108(1):153–156.

Grainger JR. Correct use of aerosol inhalers. Can Med Assoc J 1977;116:584–585.

Kim CS , Eldridge MA , Sackner MA . Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 1987;135:157–164.

Riley DJ , Liu RT , Edelman NH . Enhanced response to aerosolized bronchodilator therapy in asthma using respiratory maneuvers. Chest 1979;76:501–507.

Shak S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 1995;107(2, suppl):65S–70S.

Svedmyr N. Clinical advantages of the aerosol route of drug administration. Respir Care 1991;36(9):922–930.

Tag El-Din MA , Palmer LB , El-Tayeb MN , Kalil I , Gabr MS . Nebulizer therapy with antibiotics in chronic suppurative lung disease. J Aerosol Med 1994;7(4):345–350.

Woolf CR . Correct use of pressurized aerosol inhalers. Can Med Assoc J 1979;121:710–711.